Study of the impact of the Flash Glucose Monitoring System(FGM) on glycometabolism of type 2 diabetic patients

Study of the impact of the Flash Glucose Monitoring System(FGM) on glycometabolism of type 2 diabetic patients - Study of the impact of the Flash Glucose Monitoring System(FGM) on glycometabolism of type 2 diabetic patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000026452

Enrollment

100

Registered

2017-03-10

Start date

2017-06-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Interventions

Encourage to improve life style by using Flash glucose monitoring system(FGM) Encourage to improve life style by using conventional device for self measurement of blood glucose(SMBG)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Type 2 diabetes mellitus HbA1c 7.5% or more and less than 8.5%

Exclusion criteria

Exclusion criteria: Diabetic nephropathy (eGFR<30ml/min/1.73m2) Dialysis patient Receiving insulin therapy Proliferative diabetic retinopathy or preproliferative retinopathy Subjects who can not properly operate the device to be used

Design outcomes

Primary

Measure	Time frame
HbA1c	—

Secondary

Measure	Time frame
glucose cariability patient satisfaction blood pressure body weight	—

Countries

Japan

Contacts

Public ContactMotomitsu Goto

Nagoya University Graduate School of Medicine Endocrinology and Diabetes

goto@med.nagoya-u.ac.jp052-744-2142

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026